MedPath

Women's Cancer Care Associates, LLC

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

1

Active:0
Completed:1

Trial Phases

1 Phases

Phase 3:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Phase 3
1 (100.0%)

Trial of Cisplatin Plus Radiation Followed by Carbo and Taxol Vs. Sandwich Therapy of Carbo and Taxol Followed Radiation Then Further Carbo and Taxol

Phase 3
Completed
Conditions
Endometrial Clear Cell Adenocarcinoma
Endometrial Serous Adenocarcinoma
Stage IVA Uterine Corpus Cancer
Stage IIIC Uterine Corpus Cancer
Stage IIIA Uterine Corpus Cancer
Stage IIIB Uterine Corpus Cancer
Interventions
First Posted Date
2015-07-17
Last Posted Date
2024-07-23
Lead Sponsor
Women's Cancer Care Associates, LLC
Target Recruit Count
48
Registration Number
NCT02501954
Locations
🇺🇸

Greater Baltimore Medical Center, Baltimore, Maryland, United States

🇺🇸

Munson Health Care, Traverse City, Michigan, United States

🇺🇸

Atlantic Health, Morristown, New Jersey, United States

and more 4 locations

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.